BPA Call 36C25525A0007-36C25526N0054
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a task order valued at $3,116 under a Blanket Purchase Agreement (BPA) call for Oncotype DX Testing Services by the Department of Veterans Affairs' Veterans Integrated Service Network 15 (VISN 15). The award, issued on March 16, 2026, with an ultimate completion date of March 15, 2027, is structured as a firm fixed-price contract with no set-aside designation. Performance will take place in Marion,...
- Exact Sciences Corporation received a $3,453.96 task order award on March 16, 2026, from Veterans Integrated Service Network 15 (VISN 15) for Oncotype DX testing services at the Leavenworth Department of Veterans Affairs Medical Center. This firm fixed-price delivery order falls under a blanket purchase agreement established on March 16, 2025, with a total ceiling value of $1,071,290.72 through March 15, 2027, which supports oncology diagnostic testing across seven VA medical facilities in the...
- Exact Sciences Corporation, operating through its Exact Sciences Laboratories, LLC division, received a task order award valued at $3,453.96 from Veterans Integrated Service Network 15 on March 16, 2026, for Oncotype DX testing services supporting the Topeka Veterans Affairs Medical Center. This firm fixed-price delivery order is issued under a broader $1,071,290.72 blanket purchase agreement established between VISN 15 and Exact Sciences on March 16, 2025, which provides a framework for...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a task order under a Blanket Purchase Agreement (BPA) for Oncotype DX testing services by Veterans Integrated Service Network 15 (VISN 15), a component of the Department of Veterans Affairs. This firm fixed-price contract, awarded on March 16, 2026, carries a ceiling value of $31,328.88 with an ultimate completion date of March 15, 2027. The contract was issued without a set-aside designation,...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, has been awarded a Firm Fixed Price task order under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule Blanket Purchase Agreement with the Department of Veterans Affairs Veterans Integrated Service Network 15. The contract, valued at $10,442.96, was awarded on March 16, 2026, with an ultimate completion date of March 15, 2027, and will be performed in Kansas City, MO. This...
- This is a firm fixed-price task order valued at $27,712.76 awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 15 to Exact Sciences Corporation's Exact Sciences Laboratories, LLC division. The task order is for Oncotype DX testing services in support of the St. Louis VA Medical Center. Oncotype DX is a genomic test used to assess the risk of cancer recurrence and guide treatment decisions. This task order is part of a larger $4 million blanket purchase agreement...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a delivery order on October 1, 2022, valued at $203,932.36 for Oncotype DX testing services to support the Department of Veterans Affairs' Veterans Integrated Service Network 7 (VISN 7). The contract, which will be completed by July 31, 2027, operates under a firm fixed-price arrangement with no set-aside designation, enabling VISN 7 to procure specialized genomic testing services at a competitive...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a delivery order valued at $20,385.80 by Veterans Integrated Service Network 16 (VISN 16) on October 1, 2024, for Oncotype DX Breast Assay testing services. This firm fixed-price delivery order represents a task order call against the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule, under which Exact Sciences holds multiple blanket purchase agreements with the...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a delivery order valued at $594,081.12 for Oncotype gene expression breast cancer testing services by the Department of Veterans Affairs' Veterans Integrated Service Network 8 (VISN 8). The contract, awarded on May 15, 2022, operates under a firm fixed-price structure with an ultimate completion date of May 14, 2027, and will be performed in Tampa, Florida. This delivery order was issued without a...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, received a $52.2K firm fixed-price Blanket Purchase Agreement (BPA) call from Veterans Integrated Service Network 17 (VISN 17), a Veterans Affairs civilian agency component, for Oncotype DX gene expression profiling services. The contract award was issued on June 5, 2026, with an ultimate completion date of June 4, 2027, and was performed at the contractor's facility in Temple, Texas. This award was not issued...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- V797D70053-36C25525A0007Blanket Purchase Agreement
- 36C25525A0007-36C25526N0054BPA Call
Exact Sciences Corporation, operating through its Exact Sciences Laboratories, LLC division, was awarded a $24,258.80 firm fixed-price task order by Veterans Integrated Service Network 15 on March 16, 2026, in support of Oncotype DX testing services at the St. Louis Veterans Affairs Medical Center. This task order was issued under a larger blanket purchase agreement established on March 16, 2025, with a $1.07M ceiling value through March 15, 2027, which provides a framework for oncology diagnostic testing services across seven VA medical facilities in the central United States. The award carries no set-aside designation and falls under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), reflecting Exact Sciences' competitive positioning as a specialized provider of proprietary genomic diagnostic services to the Department of Veterans Affairs. Exact Sciences specializes in Oncotype DX gene expression profiling assays that analyze mRNA expression in cancer tumor tissue to assess recurrence risk and predict treatment responsiveness for breast, prostate, and colorectal cancers. The company maintains an extensive portfolio of federal contract vehicles across multiple Veterans Integrated Service Networks, the Defense Health Agency, and Department of Defense medical commands, with individual awards ranging from approximately $3,000 to $2.9M. This particular task order supports the VA's oncology program capabilities and represents one component of the company's sustained federal demand for specialized cancer diagnostic testing services delivered across multiple facility locations nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 1/22/26 |